References
- Leris C, Mokbel K. The prevention of breast cancer: an overview. Curr Med Res Opin 2001;16:252–7
- Mokbel K, Kirkpatrick KL. Recent advances in breast cancer (The 24th San Antonio Breast Cancer Symposium). Curr Med Res Opin 2002;18:26–9
- Cuzick J. Update on new studies in Europe. Eur J Cancer 2002;38:544 (Abstr 20)
- Fisher B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–88
- Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352(9122):98–101
- Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998;352:93–7
- Tobias JS. The ATAC (Arimidex, Tamoxifen Alone or in Combination) adjuvant breast cancer trial in postmenopausal women. Eur J Cancer 2002;38:592 (Abstr 202)
- Loman N, Johannson O, Bendahl P-O, Borg A, Ferno M, Olsson AH. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 1998;83: 310–19
- King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001;286:2251–6
- Veronesi U, De Palo G, Marubini E, et al. Randomised trial of fenesteride to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 1999;91:1847–56
- Decensi A, Johansson H, Miceli R, Mariani L, Camerini T, Cavadini E, et al. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1047–53
- Pollak M. Biological foundations of breast cancer prevention strategies. Eur J Cancer 2002;38:543 (Abstr 17)
- Elkak AE, Mokbel K. Pure antioestrogens (review). Curr Med Res Opin 2001;17:282–9